camel

JCN Newswire

Universities and DENSO Develop Biosensor to Detect SARS-CoV-2 and Accelerate Development for Practical Application

TOKYO, Oct 21, 2021 - (JCN Newswire via SEAPRWire.com) - Tokai University, Toyohashi University of Technology, Chubu University, and DENSO Corporation have been developing testing equipment to detect SARS-CoV-2 with support from the Japan Agency for Medical Research and Development (AMED)(1). Universities and DENSO announced today that the group has...
JCN Newswire

Hitachi, Tohoku University and Kyoto University Become World’s First to Establish Technology for Highly Efficient, High-quality Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT

TOKYO, Oct 19, 2021 - (JCN Newswire via SEAPRWire.com) - Hitachi, Ltd. (TSE: 6501), Tohoku University and Kyoto University have become the world's first (1) to establish technology for the highly efficient and high-quality production of actinium-225 (225Ac), a substance required for a form of radiation therapy known as targeted...
JCN Newswire

Mitsubishi Corporation Releases Roadmap to a Carbon Neutral Society

TOKYO, Oct 18, 2021 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Corporation (MC) is pleased to announce that it has established new greenhouse-gas (GHG) emissions reduction targets and energy-transformation (EX) investment guidelines.In recognition of its multi-industry interests and business activities. MC will continue to simultaneously fulfill its responsibility to provide...
JCN Newswire

Evans and TOYOTA GAZOO Racing Seal Second in Spain

Toyota City, Japan, Oct 18, 2021 - (JCN Newswire via SEAPRWire.com) - Elfyn Evans finished second overall at the Rally de Espana to set up a final-round FIA World Rally Championship title decider with his TOYOTA GAZOO Racing World Rally Team team-mate Sebastien Ogier, who finished fourth.Car 33 (Elfyn Evans,...
JCN Newswire

Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) in Two Different Types of Cancer

TOKYO and KENILWORTH, N.J., Oct 18, 2021 - (JCN Newswire via SEAPRWire.com) - Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted...
Close